Invasive fungal infections remain the leading causes of morbidity and mortality in neonates, especially preterm and very low birth weight infants. Most invasive fungal infections are due to Candida or Aspergillus species, and other fungi are increasingly reported and described. Appropriate identification and treatment are required to augment activity and reduce the toxicity of antifungal drugs. Successful use of antifungals in the vulnerable neonatal population is important for both prevention and treatment of infection. Strategies for prevention, including prophylactic antifungal therapy as well as reducing exposure to modifiable risk factors, like limiting antibiotic exposure, discontinuation of central catheters, and hand hygiene are key techniques to prevent and decrease rates of invasive fungal infections. In conclusion, this is a review of the most common causes, prevention strategies, prophylaxis, and treatment of invasive fungal infections in neonates.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Pediatric Research Open Access 19 January 2022
Subscribe to Journal
Get full journal access for 1 year
only $9.15 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Stoll, B. J. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110, 285–291 (2002).
Benjamin, D. K. et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117, 84–92 (2006).
Fridkin, S. K., Kaufman, D., Edwards, J. R., Shetty, S. & Horan, T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 117, 1680–1687 (2006).
Cotten, C. M. et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 118, 717–722 (2006).
Clerihew, L., Lamagni, T. L., Brocklehurst, P. & McGuire, W. Invasive fungal infection in very low birthweight infants: National Prospective Surveillance Study. Arch. Dis. Child. Fetal Neonatal Ed. 91, https://doi.org/10.1136/adc.2005.082024 (2006).
Saiman, L. et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr. Infect. Dis. J. 19, 319–324 (2000).
Aliaga, S. et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics 133, 236–242 (2014).
Chitnis A. S. et al. Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009. Pediatrics 130, https://doi.org/10.1542/peds.2011-3620 (2012).
Benedict, K. et al. Neonatal and pediatric candidemia: results from population-based active laboratory surveillance in four US locations, 2009-2015. J. Pediatr. Infect. Dis. Soc. 7, E78–E85 (2018).
Lausch, K. R. et al. Pediatric Candidemia epidemiology and morbidities: a nationwide cohort. Pediatr. Infect. Dis. J. 38, 464–469 (2019).
Makhoul, I. R., Sujov, P., Smolkin, T., Lusky, A. & Reichman, B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 109, 34–39 (2002).
Adams-Chapman, I. et al. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J. Pediatr. 163, https://doi.org/10.1016/j.jpeds.2013.04.034 (2013).
Correa-Rocha, R. et al. Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7. Pediatr. Res. 71, 590–597 (2012).
Carr, R. Neutrophil production and function in newborn infants. Br. J. Haematol. 110, 18–28 (2000).
Arsenault, A. B. & Bliss, J. M. Neonatal candidiasis: new insights into an old problem at a unique host-pathogen interface. Curr. Fungal Infect. Rep. 9, 246–252 (2015).
Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379–390 (2007).
Yu, Y. et al. Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients. Am. J. Perinatol. 30, 589–594 (2013).
Mahieu, L. M., Van Gasse, N., Wildemeersch, D., Jansens, H. & Ieven, M. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient. Pediatr. Crit. Care Med. 11, 240–245 (2010).
Saiman, L. et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr. Infect. Dis. J. 20, 1119–1124 (2001).
Botas, C. M., Kurlat, I., Young, S. M. & Sola, A. Disseminated Candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics 95, 883–887 (1995).
Stoll, B. J. et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 104, e63–e63 (1999).
Neu, J. Gastrointestinal development and meeting the nutritional needs of premature infants. Am. J. Clin. Nutr. 85, 629S–634S (2007).
Evans, N. J. & Rutter, N. Development of the epidermis in the newborn. Biol. Neonate 49, 74–80 (1986).
Benjamin, D. K. et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126, https://doi.org/10.1542/peds.2009-3412 (2010).
Faix, R. G., Kovarik, S. M., Shaw, T. R. & Johnson, R V. Mucocutaneous and invasive candidiasis among very low birth weight (<1,500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 83, 101–107 (1989).
Adderson, E. E., Pappin, A. & Pavia, A. T. Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. J. Pediatr. Surg. 33, 1463–1467 (1998).
Coates, E. W., Karlowicz, M. G., Croitoru, D. P. & Buescher, E. S. Distinctive distribution of pathogens associated with peritonitis in neonates with focal intestinal perforation compared with necrotizing enterocolitis. Pediatrics 116, e241–e246 (2005).
Shetty, S. S. et al. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr. Infect. Dis. J. 24, 601–604 (2005).
Manzoni, P. et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 118, 2359–2364 (2006).
Manzoni, P. et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J. Perinat. Med. 35, 220–226 (2007).
Bendel, C. M. Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Semin. Perinatol. 27, 357–364 (2003).
Lee, J. H. et al. Risk factors for invasive candidiasis in infants >1500g birth weight. Pediatr. Infect. Dis. J. 32, 222–226 (2013).
Manzoni, P. et al. Hyperglycaemia as a possible marker of invasive fungal infection in preterm neonates. Acta Paediatr. 95, 486–493 (2006).
Guida, J. D., Kunig, A. M., Leef, K. H., McKenzie, S. E. & Paul, D. A. Platelet count and sepsis in very low birth weight neonates: Is there an organism-specific response. Pediatrics 111, 1411–1415 (2003).
Benjamin, D. K. et al. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 106, 712–718 (2000).
Manzoni, P. et al. Is thrombocytopenia suggestive of organism-specific response in neonatal sepsis? Pediatr. Int. 51, 206–210 (2009).
Kassner, E. G. et al. Pulmonary candidiasis in infants: clinical, radiologic, and pathologic features. Am. J. Roentgenol. 137, 4 (1981).
Bodey, G. P. & Luna, M. Skin lesions associated with disseminated candidiasis. JAMA 229, 1466–1468 (1974).
CHEN, J. ‐Y. Neonatal candidiasis associated with meningitis and endophthalmitis. Pediatr. Int. 36, 261–265 (1994).
Noyola, D. E., Fernandez, M., Moylett, E. H. & Baker, C. J. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin. Infect. Dis. 32, 1018–1023 (2001).
Benjamin, D. K., Poole, C., Steinbach, W. J., Rowen, J. L. & Walsh, T. J. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 112, 634–640 (2003).
Fernandez, M., Moylett, E. H., Noyola, D. E. & Baker, C. J. Candida meningitis in neonates: a 10-year review. Clin. Infect. Dis. 31, 458–463 (2000).
Faix, R. G. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J. Pediatr. 105, 616–622 (1984).
Oleinik, E. M., Della-Latta, P., Rinaldi, M. G. & Saiman, L. Candida lusitaniae osteomyelitis in a premature infant. Am. J. Perinatol. 10, 313–315 (1993).
Evdoridou, J., Roilides, E., Bibashi, E. & Kremenopoulos, G. Multifocal osteoarthritis due to Candida albicans in a neonate: serum level monitoring of liposomal amphotericin B and literature review. Infection 25, 112–116 (1997).
Harris, M. C. et al. Candidal arthritis in infants previously treated for systemic candidiasis during the newborn period: report of three cases. Pediatr. Emerg. Care 16, 249–251 (2000).
Cohen-Wolkowiez, M. et al. Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. J. Perinatol. 27, 97–100 (2007).
Kaufman, D. A., Coggins, S. A., Zanelli, S. A. & Weitkamp, J.-H. Congenital cutaneous candidiasis: prompt systemic treatment is associated with improved outcomes in neonates. Clin. Infect. Dis. 64, 1387–1395 (2017).
Darmstadt, G. L., Dinulos, J. G. & Miller, Z. Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics 105, 438–444 (2000).
Roqué, H., Abdelhak, Y. & Young, B. K. Intra amniotic candidiasis. Case report and meta-analysis of 54 cases. J. Perinatal Med. 27, 253–262 (1999).
Robinson, J. L. et al. Characteristics and outcome of infants with candiduria in neonatal intensive care—a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect. Dis. 9, 183 (2009).
Phillips, J. R. & Karlowicz, M. G. Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 16, 190–194 (1997).
Benjamin, D. K., Fisher, R. G., McKinney, R. E. & Benjamin, D. K. Candidal mycetoma in the neonatal kidney. Pediatrics 104, 1126–1129 (1999).
Bryant, K., Maxfield, C. & Rabalais, G. Renal candidiasis in neonates with candiduria. Pediatr. Infect. Dis. J. 18, 959–963 (1999).
Kaplan, M., Eidelman, A. I., Dollberg, L. & Abu-Dalu, K. Necrotizing bowel disease with Candida peritonitis following severe neonatal hypothermia. Acta Paediatr. Scand. 79, 876–879 (1990).
Berenguer, J. et al. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infection. Diagn. Microbiol. Infect. Dis. 17, 103–109 (1993).
Baley, J. E., Kliegman, R. M. & Fanaroff, A. A. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 73, 144–152 (1984).
Methee Chayakulkeeree, P. P. Recent progress in the diagnosis of pathogenic Candida species in blood culture. Mycopathologia 181, 363–369 (2016).
Schelonka, R. L. & Moser, S. A. Time to positive culture results in neonatal Candida septicemia. J. Pediatr. 142, 564–565 (2003).
Karageorgopoulos, D et al. EV-CI, 2011 undefined. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin. Infect. Dis. 52, 750–770 (2011).
Goudjil, S. et al. (1–3)-β-D-glucan levels in candidiasis infections in the critically ill neonate. J. Matern. Fetal Neonatal Med. 26, 44–48 (2012).
Goudjil, S. et al. Blood product transfusions are associated with an increase in serum (1-3)-beta-d-glucan in infants during the initial hospitalization in neonatal intensive care unit (NICU). J. Matern. Fetal Neonatal Med. 30, 933–937 (2017).
Usami, M. et al. Positive (1->3)-beta-D-glucan in blood components and release of (1->3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 42, 1189–1195 (2002).
Smith, P. B. et al. Quantification of 1,3-β-D-glucan levels in children: preliminary data for diagnostic use of the β-glucan assay in a pediatric setting. Clin. Vaccin. Immunol. 14, 924–925 (2007).
Mennink-Kersten, M. A., Warris, A. & Verweij, P. E. 1,3-β-D-Glucan in patients receiving intravenous amoxicillin–clavulanic acid. N. Engl. J. Med. 354, 2834–2835 (2006).
Marty, F. M. et al. Reactivity of (1→3)-β-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob. Agents Chemother. 50, 3450–3453 (2006).
Mennink-Kersten, M. A., Ruegebrink, D. & Verweij, P. E. Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity. Clin. Infect. Dis. 46, 1930–1931 (2008).
Mennink-Kersten, M. A. & Verweij, P. E. Non-culture-based diagnostics for opportunistic fungi. Infect. Dis. Clin. N. Am. 20, 711–727 (2006).
Hellerstein, S. Urinary tract infections: old and new concepts. Pediatr. Clin. N. Am. 42, 1433–1457 (1995).
Karlowicz, M. G. Candidal renal and urinary tract infection in neonates. Semin. Perinatol. 27, 393–400 (2003).
Wynn, J. L. et al. Outcomes following candiduria in extremely low birth weight infants. Clin. Infect. Dis. 54, 331–339 (2012).
Steinbach, W. J. Pediatric aspergillosis: disease and treatment differences in children. Pediatr. Infect. Dis. J. 24, 358–364 (2005).
Groll, A. H. et al. Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin. Infect. Dis. 27, 437–452 (1998).
Kimura, H., Mitsuto, I., Taguchi, R., Anzawa, K. & Mochizuki, T. Primary cutaneous aspergillosis caused by Aspergillus tamarii in a premature infant with extremely low birthweight: a case report with short review. J. Dermatol. 45, 622–625 (2018).
Burgos, A. et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 121, e1286–e1294 (2008).
Singer, S. et al. Outbreak of systemic aspergillosis in a neonatal intensive care unit. Mycoses 41, 223–227 (1998).
McCarty, J. M., Flam, M. S., Pullen, G., Jones, R. & Kassel, S. H. Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. J. Pediatr. 108, 721–724 (1986).
Rowen, J., Correa, A., Sokol, D., Hawkins, H., Levy, M. & Edwards, M. Invasive aspergillosis in neonates. The Pediatr Infect Dis J. 11, 576–582 (1992).
Woodruff, C. A. & Hebert, A. A. Neonatal primary cutaneous aspergillosis: case report and review of the literature. Pediatr. Dermatol. 19, 439–444 (2002).
Gallais, F. et al. Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature. BMC Infect. Dis. 17, https://doi.org/10.1186/s12879-017-2646-8 (2017).
Phute, S. U. & Bhakre, J. B. Aspergillus fumigatus meningitis in a preterm. https://pubmed.ncbi.nlm.nih.gov/21149907/ (2010).
Roncati, L., Barbolini, G., Fano, R. A. & Rivasi, F. Fatal Aspergillus flavus infection in a neonate. Fetal Pediatr. Pathol. 29, 239–244 (2010).
Herron, M. D., Vanderhooft, S. L., Byington, C. & King, J. D. Aspergillosis in a 24-week newborn: a case report. J. Perinatol. 23, 256–259 (2003).
Warris, A. et al. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin. Microbiol. Infect. 25, 1096–1113 (2019).
Voigt, K. & Kirk, P. M. in Encyclopedia of Food Microbiology 2nd edn, 54–67 (Elsevier, 2014).
Roilides, E., Zaoutis, T. E., Katragkou, A., Benjamin, D. K. & Walsh, T. J. Zygomycosis in neonates: an uncommon but life-threatening infection. Am. J. Perinatol. 26, 565–573 (2009).
Roilides, E., Zaoutis, T. E. & Walsh, T. J. Invasive zygomycosis in neonates and children. Clin. Microbiol. Infect. 15, 50–54 (2009).
Agarwal, K., Sharma, M., Singh, S. & Jain, M. Antemortem diagnosis of gastrointestinal mucormycosis in neonates: report of two cases and review of literature. Indian J. Pathol. Microbiol. 49, 430–432 (2006).
Mitchell, S., Gray, J., Morgan, M. & Lancet, M. H.-T. Nosocomial Infection with Rhizopus Microsporus in Preterm Infants: Association with Wooden Tongue Depressors (Elsevier, 1996).
Duffy, J. et al. Mucormycosis outbreak associated with hospital linens. Pediatr. Infect. Dis. J. 33, 472–476 (2014).
Centers for Disease Control and Prevention. Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings-Minnesota. Morbid. Mortal. Wkly Rep. 27, 33–34 (1978).
Dennis, J. E., Rhodes, K. H., Cooney, D. R. & Roberts, G. D. Nosocomial Rhizopus infection (zygomycosis) in children. J. Pediatr. 96, 824–828 (1980).
Mantadakis, E. & Samonis, G. Clinical presentation of zygomycosis. Clin. Microbiol. Infect. 15, 15–20 (2009).
Roden, M. M. et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41, 634–653 (2005).
Veleminsky, M. S., Noll, P., Hanzl, M. & Veleminsky, M. J. Necrotizing enterocolitis in children with low birth-weight induced with mucormycose strains. Neuro Endocrinol. Lett. 29, 1021–1025 (2008).
Hammond, S. P. et al. Molecular methods to improve diagnosis and identification of mucormycosis. J. Clin. Microbiol. 49, 2151–2153 (2011).
Ashbee, H. R., Leck, A. K., Puntis, J. W. L., Parsons, W. J. & Evans, E. G. V. Skin colonization by Malassezia in neonates and infants. Infect. Control Hosp. Epidemiol. 23, 212–216 (2002).
Zomorodain, K. et al. Molecular analysis of Malassezia species isolated from hospitalized neonates. Pediatr. Dermatol. 25, 312–316 (2008).
Richet, H. M., McNeil, M. M., Edwards, M. C. & Jarvis, W. R. Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit. J. Clin. Microbiol. 27, 1197–1200 (1989).
Aschner, J. L., Punsalang, A. J., Maniscalco, W. M. & Menegus, M. A. Percutaneous central venous catheter colonization with Malassezia furfur: incidence and clinical significance. Pediatrics 80, 535–539 (1987).
Ilahi, A. et al. Molecular epidemiology of a Malassezia pachydermatis neonatal unit outbreak. Med. Mycol. 56, 69–77 (2018).
Huang, C. Y. et al. Systemic infection caused by Malassezia pachydermatis in infants: case series and review of the literature. Pediatr. Infect. Dis. J. 39, 444–448 (2020).
Marcon, M. J. & Powell, D. A. Epidemiology, diagnosis, and management of Malassezia furfur systemic infection. Diagn. Microbiol. Infect. Dis. 7, 161–175 (1987).
Kessler, A. T., Kourtis, A. P. & Simon, N. Peripheral thromboembolism associated with Malassezia furfur sepsis. Pediatr. Infect. Dis. J. 21, 356–357 (2002).
Cornu, M. et al. Evaluation of the (1,3)-ß-D-glucan assay for the diagnosis of neonatal invasive yeast infections. Med. Mycol. 56, 78–87 (2018).
Vuran, E., Karaarslan, A., Karasartova, D., Turegun, B. & Sahin, F. Identification of Malassezia species from Pityriasis versicolor lesions with a new multiplex PCR method. Mycopathologia 177, 41–49 (2014).
Honnavar, P. et al. Identification of Malassezia species by MALDI-TOF MS after expansion of database. Diagn. Microbiol. Infect. Dis. 92, 118–123 (2018).
MAXSON, S., MILLER, S. F. & TRYKA, A. F. S. G. Perinatal blastomycosis. Pediatr. Infect. Dis. J. 11, 760–763 (1992).
Watts, E. A., Gard, P. D. & Tuthill, S. W. First reported case of intrauterine transmission of blastomycosis. Pediatr. Infect. Dis. J. 2, 308–310 (1983).
Linsangan, L. C. & Ross, L. A. Coccidioides immitis infection of the neonate: two routes of infection. Pediatr. Infect. Dis. J. 18, 171–173 (1999).
Hyatt, H. W. Coccidioidomycosis in a 3-week-old infant. Am. J. Dis. Child. 105, 93–98 (1963).
Christian, J. R., Sarre, S. G., Peers, J. H., Salazar, E. & Rosario, J. Pulmonary coccidioidomycosis in a twenty-one-day-old infant: report of a case and review of the literature. AMA J. Dis. Child. 92, 66–74 (1956).
Shafai, T. Neonatal coccidioidomycosis in premature twins. Am. J. Dis. Child. 132, 634 (1978).
Cheng, M. F., Chiou, C. C., Liu, Y. C., Wang, H. Z. & Hsieh, K. S. Cryptococcus laurentii fungemia in a premature neonate. J. Clin. Microbiol. 39, 1608–1611 (2001).
Nakwan, N., Ngerncham, S., Srisuparp, P., Lapphra, K. & Chokephaibulkit, K. Cryptococcus neoformans septicemia in an immunocompetent neonate: first case report in Thailand. Southeast Asian J. Trop. Med. Public Health 39, 697–700 (2008).
Patel, M., Beckerman, K. P., Reznik, S., Madan, R. P. & Goldman, D. L. Transplacental transmission of Cryptococcus neoformans to an HIV-exposed premature neonate. J. Perinatol. 32, 235–237 (2012).
O’Reilly, D. A. A rare case of neonatal cryptococcal meningitis in an HIV-unexposed 2-day-old infant: the youngest to date? Paediatr. Int. Child Health 36, 154–156 (2016).
Salazar, G. E. & Campbell, J. R. Trichosporonosis, an unusual fungal infection in neonates. Pediatr. Infect. Dis. J. 21, 161–165 (2002).
Rowen, J. L., Atkins, J. T., Levy, M. L., Baer, S. C. & Baker, C. J. Invasive fungal dermatitis in the < or = 1000-gram neonate. Pediatrics 95, 682–687 (1995).
Fisher, D. J. et al. Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 12, 149–155 (1993).
Murphy, N. et al. Infection and colonisation of neonates by Hansenula anomala. Lancet 327, 291–293 (1986).
Aragão, P. A. et al. Pichia anomala outbreak in a nursery: exogenous source? Pediatr. Infect. Dis. J. 20, 843–848 (2001).
Nagarathnamma, T. et al. Outbreak of Pichia kudriavzevii fungaemia in a neonatal intensive care unit. J. Med. Microbiol. 66, 1759–1764 (2017).
Taj-Aldeen, S. J., Doiphode, S. H. & Han, X. Y. Kodamaea (Pichia) ohmeri fungaemia in a premature neonate. J. Med. Microbiol. 55, 237–239 (2006).
Grenouillet, F. et al. Pichia fabianii fungemia in a neonate. Pediatr. Infect. Dis. J. 29, 191 (2010).
Chakrabarti, A. et al. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in northern India. J. Clin. Microbiol. 39, 1702–1706 (2001).
Bhally, H. S. et al. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med. Mycol. 44, 185–187 (2006).
Kicklighter, S. D., Springer, S. C., Cox, T., Hulsey, T. C. & Turner, R. B. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 107, 293–298 (2001).
Manzoni, P. et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N. Engl. J. Med. 356, 2483–2495 (2007).
Leonart, L. P. et al. Fluconazole doses used for prophylaxis of invasive fungal infection in neonatal intensive care units: a network meta-analysis. J. Pediatr. 185, 129–135.e6 (2017).
Benjamin, D. K. et al. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA 311, 1742–1749 (2014).
Kaufman, D. et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 345, 1660–1666 (2001).
Ericson, J. E. et al. Fluconazole prophylaxis for the prevention of candidiasis in premature infants: a meta-analysis using patient-level data. Clin. Infect. Dis. 63, 604 (2016).
Pappas, P. G. et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 62, e1–e50 (2016).
CD, H., DS, B., NM, G., MP, C. & B, J. Review of fluconazole treatment and prophylaxis for invasive candidiasis in neonates. J. Pediatr. Pharmacol. Ther. 26, 115–122 (2021).
Greenberg, R. G. et al. Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J. Pediatr. 161, https://doi.org/10.1016/J.JPEDS.2012.01.053 (2012).
Puia-Dumitrescu, M. & Smith, P. B. Antifungal drugs in newborns and children. Pediatr. Clin. N. Am. 64, 1389–1402 (2017).
Hsieh, E. M. et al. Medication use in the neonatal intensive care unit. Am. J. Perinatol. 31, 811–821 (2014).
Morrison, V. & Weisdorf, D. The spectrum of Malassezia infections in the bone marrow transplant population. Bone Marrow Transplant. 26, 645–648 (2000).
Hawser, S. P. & Douglas, L. J. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39, 2128–2131 (1995).
Ferreras-Antolín, L., Sharland, M. & Warris, A. Management of invasive fungal disease in neonates and children. Pediatr. Infect. Dis. J. 38, https://doi.org/10.1097/INF.0000000000002317 (2019).
Kaufman, D. Strategies for prevention of neonatal invasive candidiasis. Semin. Perinatol. 27, 414–424 (2003).
Benjamin, D. K. et al. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 112, 543–547 (2003).
Roth, J. G., Troy, J. L. & Esterly, N. B. Multiple cutaneous ulcers in a premature neonate. Pediatr. Dermatol. 8, 253–255 (1991).
Amod, F. C., Coovadia, Y. M., Pillay, T. & Ducasse, G. Primary cutaneous aspergillosis in ventilated neonates. Pediatr. Infect. Dis. J. 19, 482–483 (2000).
Rowen, J. L., Correa, A. G., Sokol, D. M., Hawkins, H. K. & Levy, M. L. E. M. Invasive aspergillosis in neonates: report of five cases and literature review. Pediatr. Infect. Dis. J. 11, 576–582 (1992).
Starke, J. R., Mason, E. O., Kramer, W. G. & Kaplan, S. L. Pharmacokinetics of amphotericin B in infants and children. J. Infect. Dis. 155, 766–774 (1987).
Pammi, M. Unusual fungal infections in the neonate. https://www.uptodate.com/contents/unusual-fungal-infections-in-the-neonate#H12 (2021).
Spelman, D. M. C. Invasive Malassezia infections. https://www.uptodate.com/contents/invasive-malassezia-infections?topicRef=4988&source=see_link#H8 (2021).
American Academy of Pediatrics. In: Kimberlin, D. W., Brady, M. T., Jackson, M. A., Long, S. S. editors. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018.
Koren, G. et al. Pharmacokinetics and adverse effects of amphotericin B in infants and children. J. Pediatr. 113, 559–563 (1988).
Wong-Beringer, A., Jacobs, R. A. & Guglielmo, B. J. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin. Infect. Dis. 27, 603–618 (1998).
Lestner, J. M., Smith, P. B., Cohen-Wolkowiez, M., Benjamin, D. K. Jr & Hope, W. W. Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective. Br. J. Clin. Pharmacol. 75, 1381–1395 (2013).
Testoni, D., Smith, P. B. & Benjamin, D. K. Jr. The use of antifungal therapy in neonatal intensive care. Clin. Perinatol. 39, 83 (2012).
Walsh, T. J. et al. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob. Agents Chemother. 48, 2166–2172 (2004).
Denning, D. W. & Hope, W. W. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol. 18, 195–204 (2010).
Neely, M., Rushing, T., Kovacs, A., Jelliffe, R. & Hoffman, J. Voriconazole pharmacokinetics and pharmacodynamics in children. Clin. Infect. Dis. 50, 27–36 (2010).
Howard, S. J., Felton, T. W., Gomez-Lopez, A. & Hope, W. W. Posaconazole: the case for therapeutic drug monitoring. Ther. Drug Monit. 34, 72–76 (2012).
Cinzia, A. et al. High-dose Micafungin in neonates and young infants with invasive candidiasis: results of a phase 2 study. Antimicrob. Agents Chemother. 65, https://doi.org/10.1128/AAC.02494-20 (2021).
Soltani, M. et al. Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory. Int. J. Antimicrob. Agents 28, 574–577 (2006).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Weimer, K.E.D., Smith, P.B., Puia-Dumitrescu, M. et al. Invasive fungal infections in neonates: a review. Pediatr Res 91, 404–412 (2022). https://doi.org/10.1038/s41390-021-01842-7
Pediatric Research (2022)